openPR Logo
Press release

Sexually Transmitted Diseases (STDs) Drug Market to Expand with a CAGR of 11.2% due to 2025

02-05-2019 07:14 PM CET | Health & Medicine

Press release from: Transparency Market Research

Sexually Transmitted Diseases (STDs) Drug Market to Expand with

Global Sexually Transmitted Diseases Drug Market:

Sexually transmitted diseases (STDs), also referred as venereal diseases are infections that can pass from person to person during sex. These diseases are caused mainly due to bacteria, viruses, and / or parasites. Sexually transmitted diseases (STDs) often go undiagnosed because these infections usually do not exhibit visual symptoms. Changes in urination, Pain during sex, unusual discharge from the penis, abnormal vaginal discharge or bleeding, bumps or sores, pain in the pelvic or abdominal region, burning or itching in the vaginal area are most common symptoms for sexually transmitted diseases (STDs).

Read Report Overview @ https://www.transparencymarketresearch.com/sexually-transmitted-disease-drugs-market.html

These all symptoms help to diagnose sexually transmitted diseases (STDs). Nucleic Acid Amplification Tests (NAAT), direct fluorescent tests and others test recommended by healthcare specialist to confirm sexually transmitted diseases (STDs). Chlamydia, gonorrhea, HIV/AIDS, Human papillomavirus infection and syphilis are the most common types of sexually transmitted diseases (STDs. As per WHO 2015 report, near about 1.1 billion people had sexually transmitted diseases (STDs) other than HIV/AIDS. About 500 million people were infected with either chlamydia, gonorrhea syphilis or trichomoniasis. At least 250 million women suffering from human papillomavirus while 530 million case find with genital herpes.
sexually transmitted diseases

Request Report Sample @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=34043

Hospital Segment to Turn Lucrative, Fuelling Demand for Sexually Transmitted Disease Drugs

The global market for sexually transmitted diseases (STDs) drug is expanding significantly, owing to increased chances of infection led by increase in the life expectancy of people across the globe. Rise in incidences of unprotected sex has led to an increase in the prevalence of sexually transmitted diseases. A driving factor for the sexually transmitted diseases (STDs) drug is rising initiatives by governments and multiple agencies drawn up guidelines or recommendations for sexually transmitted diseases (STDs). Low voluntary screening rate for sexually transmitted diseases (STDs) is major restrain for this market.

The global sexually transmitted diseases (STDs) drug market can be segmented on the basis of disease type, therapy class, distribution channel, and region. On the bases of disease type, sexually transmitted diseases (STDs) drug market can be further segmented into chlamydia, gonorrhea, syphilis, human papillomavirus infection, HIV/AIDS and others.

Request Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=34043

According to therapy class sexually transmitted diseases (STDs) drug market can be segmented into antibiotics, antiviral, vaccines and others. In terms of distribution channel, the sexually transmitted diseases (STDs) drug market can be segmented into hospitals pharmacies, retail pharmacies, online pharmacies and others. In terms of revenue, the hospitals segment held a significant share of the sexually transmitted diseases (STDs) drug market in 2016.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact Us

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: roshan.k@tmr.com
Website: https://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Sexually Transmitted Diseases (STDs) Drug Market to Expand with a CAGR of 11.2% due to 2025 here

News-ID: 1562473 • Views:

More Releases from Transparency Market Research

Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights for the USD 15.9 Bn Market 2022-2031
Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights f …
The global handheld marijuana vaporizer market has witnessed remarkable growth in recent years, attributed to the increasing acceptance of medicinal marijuana and the demand for convenient and discreet consumption methods. Valued at US$ 5 billion in 2021, the market is projected to surge at a CAGR of 13.4% to reach US$ 15.9 billion by 2031. This article delves into the factors driving this growth, the evolving market landscape, and the
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And Competitors
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And …
The COVID-19 pandemic has precipitated a remarkable surge in the demand for disinfectant products, with a notable emphasis on disinfectant wipes as an essential tool in maintaining hygiene and preventing the spread of pathogens. This research report delves into the multifaceted landscape of the disinfectant wipes market, elucidating key trends, drivers, and innovations shaping the industry. 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭 @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=70359 Key Players and Market Developments Key players
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Study
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Stud …
The global 𝐭𝐢𝐬𝐬𝐮𝐞 𝐛𝐚𝐧𝐤𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 reached a value of US$ 1,056.4 million in 2017 and is projected to nearly triple to US$ 2,903.3 million by 2026, with a robust Compound Annual Growth Rate (CAGR) of approximately 12.0% from 2018 to 2026. Factors such as increasing awareness about tissue donation, technological advancements, and a growing target patient population are anticipated to propel market growth during this period. Moreover, the market is expected
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
This report by Transparency Market Research, Inc. assesses the present state and future growth potential of the global 𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐜𝐥𝐨𝐬𝐮𝐫𝐞 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭. It features a comprehensive executive summary, offering insights into various segments of the market. Additionally, the report provides detailed analysis and data on product, access type, application, end user, and regional segments within the global market. Vascular closure devices is estimated to reach a value of ~US$ 1 Bn

All 5 Releases


More Releases for STDs

STDs Diagnosis Market : Industry Growth, Size, Manufacturers, Sales and Demand
ReportsnReports recently announces a latest research report titled “Global STDs Diagnosis Market 2018” which highlights the STDs Diagnosis Market size, comprehensive STDs Diagnosis Industry dynamics and high-tech updates of global STDs Diagnosis Market with respect to STDs Diagnosis Industry opportunities, threats, challenges, constraints, cost structure and current trends in the STDs Diagnosis Industry. This independent 116 Page report based on analysis over 6 Major Key Players guarantees you will remain
Sexually Transmitted Diseases (STDs) Treatment Market Opportunity Analysis, 2018 …
Sexually transmitted disease also known as venereal diseases is a clinical syndrome of infection, acquired and transmitted through sexual activity via body fluids such as semen, vaginal fluid or blood. Causative agent of STD are bacteria, parasites, yeast, and viruses. Symptoms of STDs includes skin rashes, warts, abdominal pain or genital ulcers. STDs are detected by physical examination or assays such as ELISA (Enzyme Linked Immunosorbent Assay), rapid plasma reagin
6th International Conference on HIV/AIDS, STDs and STIs
6th International Conference on HIV/AIDS, STDs and STIs is exclusively designed for immunologists & virologist, physicians, nurses/nurse practitioners, pharmacists, psychologists, behavioral researchers, Healthcare professionals, social scientists, epidemiologists, social workers, AIDS service organization (ASO) staff, students, Researchers, Academicians, Practitioners, Early Career Scholars, students along with Industries and others engaged in endeavors related to STD AIDS research and business. As HIV/AIDS is an alarming concern throughout the world, STD AIDS 2018 will mainly
Global Diagnostic Testing of STDs Market to Reach US$108.5 bn by 2019, Propelled …
Transparency Market Research has published a new report on the global diagnostic testing of STDs market. As per the report, the global diagnostic testing of STDs market is expected to expand at an 8.10% CAGR during the period from 2013 to 2019. The report, titled ‘Diagnostic Testing of STDs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019’, states that the global diagnostic testing of
Diagnostic Testing of STDs Market Research Report Forecast to 2019
As per the report, the global diagnostic testing of STDs market is expected to expand at an 8.10% CAGR during the period from 2013 to 2019. The report, states that the global diagnostic testing of STDs market is expected to progress from US$65.9 bn in 2012 to US$108.5 bn by 2019. Sexually transmitted diseases (STDs), as the name itself suggests, are diseases that spread through sexual contact. STDs are primarily
Global Diagnostic Testing of STDs Market to Reach US$108.5 bn by 2019, Propelled …
Transparency Market Research has published a new report on the global diagnostic testing of STDs market. As per the report, the global diagnostic testing of STDs market is expected to expand at an 8.10% CAGR during the period from 2013 to 2019. The report, titled ‘Diagnostic Testing of STDs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019’, states that the global diagnostic testing of